Occulus
OCULUS has been a trusted partner for eye care professionals around the world for more than 125 years. With the highest attention to detail, our devices are designed and manufactured at the OCULUS headquarters, located in Wetzlar, Germany. Thanks to our 11 subsidiaries in Europe, Asia and America, and more than 200 distributors in over 80 countries, OCULUS is accessible to all customers around the globe.
Occulus sponsored articles in Myopia Profile.
Other relevant products
The following product(s) have not been specifically designed for myopia control and/or do not have regulatory approval for the same, but are listed by Myopia Profile as they have randomized controlled trial research data supporting their efficacy for myopia management. Suitability for prescribing these treatments will depend on your country and regulatory requirements of practice, and also be aware that not all products are available in all countries.
Myopia Master
he well-known Brien Holden Vision Institute has forecast that by the year 2050 one out of two individuals could be affected by myopia.Those affected have a greater risk of developing severe eye disease such as cataract or retinal detachment and eventual blindness.
Occulus resources
OCCULUS myopia management resources
Master myopia with OCULUS
David Kern, Product Manager of the Myopia master
“We listened to Eye Care Professional’s needs and designed and manufactured a device to efficiently manage myopia, the Myopia Master®. We aim to educate ECPs about the importance of axial length measurement but also learn vice versa. The partnership with Myopia Profile is best placed to accomplish that.”
The OCULUS Myopia Master® is the world’s first device to combine the important measurement methods of myopia management: axial length, refraction values and the central corneal radii. Axial length measurement today is regarded by experts as the gold standard for myopia management and a must for every myopia expert. This quick, contactless and extremely accurate measurement method is not influenced by the accommodation-status of the eye and delivers reproducible results also in children.